These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 29189980)

  • 1. Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis.
    Lachmandas E; Thiem K; van den Heuvel C; Hijmans A; de Galan BE; Tack CJ; Netea MG; van Crevel R; van Diepen JA
    Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):371-380. PubMed ID: 29189980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis.
    Fiske CT; de Almeida AS; Shintani AK; Kalams SA; Sterling TR
    Clin Vaccine Immunol; 2012 Aug; 19(8):1142-9. PubMed ID: 22675156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Innate and Acquired Immune Responses in Systemic Sclerosis Primary Peripheral Blood Mononuclear Cells (PBMCs).
    Szabo I; Badii M; Gaál IO; Szabo R; Popp RA; Joosten LAB; Crişan TO; Rednic S
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparative Investigation on Cytokine Expression in Pulmonary Tuberculosis and Comorbidity with Type 2 Diabetes Mellitus.
    Singh K; Hussain T; Gupta B; Pati S
    Int J Mycobacteriol; 2024 Apr; 13(2):165-170. PubMed ID: 38916387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia modulates M1/M2 macrophage polarization in chronic diabetic patients with pulmonary tuberculosis infection.
    Panda S; Arora A; Luthra K; Mohan A; Vikram NK; Kumar Gupta N; Singh A
    Immunobiology; 2024 Mar; 229(2):152787. PubMed ID: 38271857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of circulating LPS during Tuberculosis prevails in patients with advanced pulmonary involvement.
    Gallucci G; Santucci N; Díaz A; Bongiovanni B; Bértola D; Gardeñez W; Rassetto M; Bay ML; Bottasso O; D'Attilio L
    PLoS One; 2021; 16(9):e0257214. PubMed ID: 34506568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis between cytokines' profile, autoimmune antibodies and the duration of type 1 diabetes: A case control study in a specialized children's centre in Riyadh.
    Al-Dubayee M; Babiker A; Alkewaibeen A; Alkhalifah A; Alanazi T; Nogoud M; Alotaibi A; Alotaibi F; Almetairi F; Alrowaily MA; Masuadi E; Nasr A
    Int J Immunopathol Pharmacol; 2023; 37():3946320231209821. PubMed ID: 37953627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory and endothelial host responses in community-acquired pneumonia: exploring the relationships with HbA1c, admission plasma glucose, and glycaemic gap-a cross-sectional study.
    Dungu AM; Lundgaard AT; Ryrsø CK; Hegelund MH; Jensen AV; Kristensen PL; Krogh-Madsen R; Faurholt-Jepsen D; Ostrowski SR; Banasik K; Lindegaard B
    Front Immunol; 2024; 15():1372300. PubMed ID: 38840922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing HbA1c is associated with reduced CD8
    Hulme KD; Tong ZWM; Rowntree LC; van de Sandt CE; Ronacher K; Grant EJ; Dorey ES; Gallo LA; Gras S; Kedzierska K; Barrett HL; Short KR
    Cell Mol Life Sci; 2024 Jan; 81(1):35. PubMed ID: 38214784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset.
    Cabrera SM; Wang X; Chen YG; Jia S; Kaldunski ML; Greenbaum CJ; ; Mandrup-Poulsen T; ; Hessner MJ
    Eur J Immunol; 2016 Apr; 46(4):1030-46. PubMed ID: 26692253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Metabolic Memory on Immune Profile in Young Patients with Uncomplicated Type 1 Diabetes.
    Neubauer-Geryk J; Wielicka M; Myśliwiec M; Zorena K; Bieniaszewski L
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multifaceted analysis of immune-endocrine-metabolic alterations in patients with pulmonary tuberculosis.
    Santucci N; D'Attilio L; Kovalevski L; Bozza V; Besedovsky H; del Rey A; Bay ML; Bottasso O
    PLoS One; 2011; 6(10):e26363. PubMed ID: 22022605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal assessment of hippocampus structure in children with type 1 diabetes.
    Foland-Ross LC; Reiss AL; Mazaika PK; Mauras N; Weinzimer SA; Aye T; Tansey MJ; White NH;
    Pediatr Diabetes; 2018 Apr; ():. PubMed ID: 29675980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR15a and miR16 in Chilean type 1 diabetes patients: possible association with apoptosis, inflammatory, or autoimmunity markers.
    Garcia-Diaz DF; Camacho-Guillén P; Codner E; Pérez-Bravo F
    J Endocrinol Invest; 2018 Jan; ():. PubMed ID: 29388053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necrosis, netosis, and apoptosis in pulmonary tuberculosis and type-2 diabetes mellitus. Clues from the patient's serum.
    Rojas-Espinosa O; Arce-Mendoza AY; Islas-Trujillo S; Muñiz-Buenrostro A; Arce-Paredes P; Popoca-Galván O; Moreno-Altamirano B; Rivero Silva M
    Tuberculosis (Edinb); 2023 Dec; 143():102426. PubMed ID: 38180029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycerol contributes to tuberculosis susceptibility in male mice with type 2 diabetes.
    Martinez N; Smulan LJ; Jameson ML; Smith CM; Cavallo K; Bellerose M; Williams J; West K; Sassetti CM; Singhal A; Kornfeld H
    Nat Commun; 2023 Sep; 14(1):5840. PubMed ID: 37730757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "Quantitative proteomics reveals plasma protein profile and potential pathways in pulmonary tuberculosis patients with and without diabetes" [Tuberculosis 143 (2023) 102424].
    He X; Wang Y; Yang Y; He Q; Sun L; Jin J
    Tuberculosis (Edinb); 2024 May; 146():102481. PubMed ID: 38307742
    [No Abstract]   [Full Text] [Related]  

  • 18. Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences.
    Donovan ML; Schultz TE; Duke TJ; Blumenthal A
    Front Immunol; 2017; 8():1633. PubMed ID: 29230217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoarabinomannan Decreases Galectin-9 Expression and Tumor Necrosis Factor Pathway in Macrophages Favoring
    Chávez-Galán L; Ramon-Luing L; Carranza C; Garcia I; Sada-Ovalle I
    Front Immunol; 2017; 8():1659. PubMed ID: 29230224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17 regulates matrix metalloproteinase activity in human pulmonary tuberculosis.
    Singh S; Maniakis-Grivas G; Singh UK; Asher RM; Mauri F; Elkington PT; Friedland JS
    J Pathol; 2018 Mar; 244(3):311-322. PubMed ID: 29210073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.